News | January 27, 2008

Arbor, Medtronic Close $20 Million Valve Licensing Agreement

January 28, 2008 - Arbor Surgical Technologies Inc. closed a $20 million dollar Series C financing round led by Medtronic Inc. as part of a licensing agreement, providing Medtronic with manufacturing, marketing and distribution rights to Arbor’s advanced trilobal pericardial valve technologies.

With the closing of this event, Arbor has raised approximately $54 million dollars to date. This financing event will allow Arbor to expand clinical trials of its core technologies, the Trilogy Aortic Valve System and the sutureless TRE implantation tool. These devices are designed to enable more surgeons to perform minimally invasive heart valve procedures.

Financial terms of the license agreement have not been disclosed. Arbor retains exclusive rights to the modular Trilogy Aortic Valve System and sutureless TRE implantation technologies.

For more information: www.arborsurgical.com

Related Content

Edwards LifeSciences Recalls Sapien 3 Certitude Delivery System
News | Heart Valve Technology| January 11, 2018
The U.S. Food and Drug Administration (FDA) announced that Edwards LifeSciences is recalling its Certitude Delivery...
Videos | Heart Valve Technology| January 04, 2018
Adam Greenbaum, M.D., co-director, Center for Structural Heart Disease, Henry Ford Hospital, Detroit, explains how hi
Edwards Acquires Harpoon Medical
News | Heart Valve Technology| December 07, 2017
December 7, 2017 — Edwards Lifesciences Corp.
Videos | Heart Valve Technology| November 15, 2017
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, is the principal investigato
New Analyses Reinforce Hemodynamic Benefits of Evolut TAVR Platform in Intermediate-Risk Aortic Stenosis Patients
News | Heart Valve Technology| November 08, 2017
Medtronic plc recently presented new clinical research to support the positive clinical performance of the Evolut...
Videos | Heart Valve Technology| November 08, 2017
Philippe Genereux, M.D., co-director of the structural heart program at the Gagnon Cardiovascular Institute at Morris
Videos | Heart Valve Technology| November 08, 2017
Stephen Worthley, MB, BS, Ph.D., director of cardiac catheterization, University of Adelaide, Australia, presents the
Harpoon Mitral Valve Repair System data reported at TCT 2017
Feature | Heart Valve Technology| November 07, 2017
November 7, 2017 – A new study has found that a pioneering device to repair heart valves is safe and effective, and c
Videos | Heart Valve Technology| November 07, 2017
Ted Feldman, M.D., MSCAI FACC FESC, director of the cardiac cath lab, Evanston Hospital, explains the current state o
Overlay Init